We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 120

Flakeboard and SierraPine cay civil penalties and disgorgement of profits to settle DOJ's charges of unlawful gun jumping

  • Hogan Lovells
  • -
  • USA
  • -
  • November 13 2014

The antitrust agencies remain vigilant in prohibiting "gun jumping" the unlawful coordination of parties to a transaction during the pre-HSR

Antitrust Division addresses compliance and cooperation in criminal antitrust cases

  • Hogan Lovells
  • -
  • USA
  • -
  • September 12 2014

The Department of Justice (DOJ) made several significant criminal antitrust policy statements this week relating to corporate compliance and

Federal Circuit revives certain sham petitioning antitrust counterclaims in Tyco-mutual ANDA litigation

  • Hogan Lovells
  • -
  • USA
  • -
  • August 26 2014

In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed summary judgment on two antitrust counterclaims brought by Mutual

Second circuit takes Grimm view of continuing conspiracy theory

  • Hogan Lovells
  • -
  • USA
  • -
  • March 6 2014

In December 2013 the Second Circuit issued a key decision that restricts the prosecution of cases where the US government aims to use routine payments

Federal judge limits antitrust scrutiny of pharmaceutical reverse payments

  • Hogan Lovells
  • -
  • USA
  • -
  • February 27 2014

A federal judge in the District of New Jersey has held that only patent settlements involving a reverse monetary payment will be subject to antitrust

NY Attorney General forges new ground in scrutiny of pharmaceutical agreements with first-filer exclusivity no-challenge settlement

  • Hogan Lovells
  • -
  • USA
  • -
  • February 21 2014

The New York Attorney General's (NYAG) office has announced that it has reached a settlement with two generic drug manufacturers regarding

Federal judge limits antitrust scrutiny of pharmaceutical reverse payments to settlements involving monetary transfers

  • Hogan Lovells
  • -
  • USA
  • -
  • February 7 2014

Recently, a federal judge in the U.S. District Court for the District of New Jersey held that only patent settlements involving a reverse monetary

Judge rules non-reportable, consummated merger violates antitrust law

  • Hogan Lovells
  • -
  • USA
  • -
  • January 30 2014

On January 8 one year since the filing of the lawsuit and 18 months since the merger closed a US federal judge declared that Bazaarvoice violated

District Court blocks hospital acquisition of a physician practice, concluding that anticompetitive effects outweigh potential quality and efficiency gains from consolidation

  • Hogan Lovells
  • -
  • USA
  • -
  • January 27 2014

In the first ever FTC-litigated challenge to a hospital system's acquisition of a physician group, the U.S. District Court for Idaho ruled in favor

Judge rules non-reportable, consummated merger violates U.S. antitrust law

  • Hogan Lovells
  • -
  • USA
  • -
  • January 10 2014

One year since the filing of the lawsuit, and 18 months since the merger closed, a U.S. federal judge declared on 8 January 2014 that Bazaarvoice